Jonathan Powell

About

Jonathan Powell, M.D., Ph.D. is a physician-scientist focused on cancer immunotherapy, immunometabolism, and translational drug development. He is Head of Development at Calico and previously spent two decades at Johns Hopkins, where he was a professor of oncology and pharmacology and an associate director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy. He is also a scientific founder of Dracen Pharmaceuticals and one of the academic founders of Sitryx.

Areas of interest